9002 SMA Horizons Evaluation

Please rate your confidence in applying the following in your practice BEFORE this activity: *This question is required.

Space Cell	0 - Not Relevant	1 - Lowest	2 - Low	3 - Moderate	4 - High	5 - Highest
Reviewing pathology, genetics, and epidemiology of SMA	Reviewing pathology, genetics, and epidemiology of SMA: 0 - Not Relevant	Reviewing pathology, genetics, and epidemiology of SMA: 1 - Lowest	Reviewing pathology, genetics, and epidemiology of SMA: 2 - Low	Reviewing pathology, genetics, and epidemiology of SMA: 3 - Moderate	Reviewing pathology, genetics, and epidemiology of SMA: 4 - High	Reviewing pathology, genetics, and epidemiology of SMA: 5 - Highest
Explaining the importance of genetic testing for SMA	Explaining the importance of genetic testing for SMA: 0 - Not Relevant	Explaining the importance of genetic testing for SMA: 1 - Lowest	Explaining the importance of genetic testing for SMA: 2 - Low	Explaining the importance of genetic testing for SMA: 3 - Moderate	Explaining the importance of genetic testing for SMA: 4 - High	Explaining the importance of genetic testing for SMA: 5 - Highest
Discussing newborn screening and its importance in early diagnosis of SMA	Discussing newborn screening and its importance in early diagnosis of SMA: 0 - Not Relevant	Discussing newborn screening and its importance in early diagnosis of SMA: 1 - Lowest	Discussing newborn screening and its importance in early diagnosis of SMA: 2 - Low	Discussing newborn screening and its importance in early diagnosis of SMA: 3 - Moderate	Discussing newborn screening and its importance in early diagnosis of SMA: 4 - High	Discussing newborn screening and its importance in early diagnosis of SMA: 5 - Highest
Evaluating new and emerging therapies for SMA	Evaluating new and emerging therapies for SMA: 0 - Not Relevant	Evaluating new and emerging therapies for SMA: 1 - Lowest	Evaluating new and emerging therapies for SMA: 2 - Low	Evaluating new and emerging therapies for SMA: 3 - Moderate	Evaluating new and emerging therapies for SMA: 4 - High	Evaluating new and emerging therapies for SMA: 5 - Highest

Please rate your confidence in applying the following in your practice AFTER this activity: *This question is required.

Space Cell	0 - Not Relevant	1 - Lowest	2 - Low	3 - Moderate	4 - High	5 - Highest
Reviewing pathology, genetics, and epidemiology of SMA	Reviewing pathology, genetics, and epidemiology of SMA: 0 - Not Relevant	Reviewing pathology, genetics, and epidemiology of SMA: 1 - Lowest	Reviewing pathology, genetics, and epidemiology of SMA: 2 - Low	Reviewing pathology, genetics, and epidemiology of SMA: 3 - Moderate	Reviewing pathology, genetics, and epidemiology of SMA: 4 - High	Reviewing pathology, genetics, and epidemiology of SMA: 5 - Highest
Explaining the importance of genetic testing for SMA	Explaining the importance of genetic testing for SMA: 0 - Not Relevant	Explaining the importance of genetic testing for SMA: 1 - Lowest	Explaining the importance of genetic testing for SMA: 2 - Low	Explaining the importance of genetic testing for SMA: 3 - Moderate	Explaining the importance of genetic testing for SMA: 4 - High	Explaining the importance of genetic testing for SMA: 5 - Highest
Discussing newborn screening and its importance in early diagnosis of SMA	Discussing newborn screening and its importance in early diagnosis of SMA: 0 - Not Relevant	Discussing newborn screening and its importance in early diagnosis of SMA: 1 - Lowest	Discussing newborn screening and its importance in early diagnosis of SMA: 2 - Low	Discussing newborn screening and its importance in early diagnosis of SMA: 3 - Moderate	Discussing newborn screening and its importance in early diagnosis of SMA: 4 - High	Discussing newborn screening and its importance in early diagnosis of SMA: 5 - Highest
Evaluating new and emerging therapies for SMA	Evaluating new and emerging therapies for SMA: 0 - Not Relevant	Evaluating new and emerging therapies for SMA: 1 - Lowest	Evaluating new and emerging therapies for SMA: 2 - Low	Evaluating new and emerging therapies for SMA: 3 - Moderate	Evaluating new and emerging therapies for SMA: 4 - High	Evaluating new and emerging therapies for SMA: 5 - Highest

3. Do you intend to make changes or apply new knowledge to your practice as a result of this activity? *This question is required.

• Yes*
• I’m possibly considering changes*
• This activity affirms what I already do in practice
• No, I do not intend to make any changes

*If yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical management of patients as a result of this educational activity. Select all that apply: *This question is required.

• Order genetic testing promptly in patients with suspected SMA
• Consider carrier screening for parents
• Educate parents about genetic testing for SMA
• Emphasize the importance of newborn screening
• Educate families and patients about available therapies for SMA
• Facilitate selection of appropriate SMA therapies, taking specific patient characteristics and needs into consideration
• Other, please specify Please enter an 'other' value for this selection.

Was the format of this educational activity appropriate for the content presented? *This question is required.

• Yes
• No

Was this activity scientifically sound and free of commercial bias or influence? *This question is required.

• Yes
• No

The France Foundation would you like to send you educational opportunities relevant to your practice, emailed to the address you provided. May we have your consent? *This question is required.

• Yes
• No